Found: 470
Select item for more details and to access through your institution.
Machine learning in the prevention of heart failure.
- Published in:
- Heart Failure Reviews, 2025, v. 30, n. 1, p. 117, doi. 10.1007/s10741-024-10448-0
- By:
- Publication type:
- Article
In-hospital initiation of sodium-glucose co-transporter-2 inhibitors in patients with acute heart failure.
- Published in:
- Heart Failure Reviews, 2025, v. 30, n. 1, p. 89, doi. 10.1007/s10741-024-10446-2
- By:
- Publication type:
- Article
Cigarette Smoking, Smoking Cessation, and Heart Failure Subtypes: Insights From the Jackson Heart Study.
- Published in:
- Journal of the American Heart Association, 2024, v. 13, n. 23, p. 1, doi. 10.1161/JAHA.123.032921
- By:
- Publication type:
- Article
Long-term safety and efficacy of sodium zirconium cyclosilicate for hyperkalaemia in patients with mild/moderate versus severe/end-stage chronic kidney disease: comparative results from an open-label, Phase 3 study.
- Published in:
- Nephrology Dialysis Transplantation, 2021, v. 36, n. 1, p. 137, doi. 10.1093/ndt/gfz285
- By:
- Publication type:
- Article
Effect of Vericiguat, a Soluble Guanylate Cyclase Stimulator, on Natriuretic Peptide Levels in Patients With Worsening Chronic Heart Failure and Reduced Ejection Fraction: The SOCRATES-REDUCED Randomized Trial.
- Published in:
- 2015
- By:
- Publication type:
- journal article
Recognizing Worsening Chronic Heart Failure as an Entity and an End Point in Clinical Trials.
- Published in:
- 2014
- By:
- Publication type:
- Opinion
Management of Comorbid Diabetes Mellitus and Worsening Heart Failure.
- Published in:
- 2014
- By:
- Publication type:
- Opinion
Strategies to reduce heart failure readmissions--reply.
- Published in:
- 2014
- By:
- Publication type:
- commentary
Strategies to Reduce Heart Failure Readmissions.
- Published in:
- 2014
- By:
- Publication type:
- Letter to the Editor
Low-dose dopamine or low-dose nesiritide in acute heart failure with renal dysfunction: the ROSE acute heart failure randomized trial.
- Published in:
- 2013
- By:
- Publication type:
- journal article
Low-Dose Dopamine or Low-Dose Nesiritide in Acute Heart Failure With Renal Dysfunction.
- Published in:
- JAMA: Journal of the American Medical Association, 2013, v. 310, n. 23, p. 2533, doi. 10.1001/jama.2013.282190
- By:
- Publication type:
- Article
Need for Increased Awareness and Evidence-Based Therapies for Patients Hospitalized for Heart Failure.
- Published in:
- 2013
- By:
- Publication type:
- Opinion
Strategies and Opportunities for Drug Development in Heart Failure.
- Published in:
- JAMA: Journal of the American Medical Association, 2013, v. 309, n. 15, p. 1593, doi. 10.1001/jama.2013.1063
- By:
- Publication type:
- Article
Association of major and minor ECG abnormalities with coronary heart disease events.
- Published in:
- 2012
- By:
- Publication type:
- journal article
Association of Major and Minor ECG Abnormalities With Coronary Heart Disease Events.
- Published in:
- JAMA: Journal of the American Medical Association, 2012, v. 307, n. 14, p. 1497
- By:
- Publication type:
- Article
Heart failure with preserved ejection fraction: underdiagnosed and undertreated in patients with tricuspid regurgitation.
- Published in:
- 2024
- By:
- Publication type:
- Case Study
Ferric carboxymaltose and exercise capacity in heart failure with preserved ejection fraction and iron deficiency: the FAIR-HFpEF trial.
- Published in:
- European Heart Journal, 2024, v. 45, n. 37, p. 3789, doi. 10.1093/eurheartj/ehae479
- By:
- Publication type:
- Article
Semaglutide and diuretic use in obesity-related heart failure with preserved ejection fraction: a pooled analysis of the STEP-HFpEF and STEP-HFpEF-DM trials.
- Published in:
- European Heart Journal, 2024, v. 45, n. 35, p. 3254, doi. 10.1093/eurheartj/ehae322
- By:
- Publication type:
- Article
Identification of three mechanistic pathways for iron-deficient heart failure.
- Published in:
- European Heart Journal, 2024, v. 45, n. 26, p. 2281, doi. 10.1093/eurheartj/ehae284
- By:
- Publication type:
- Article
The transformative potential of left ventricular assist devices in advanced heart failure: no more a therapeutic orphan.
- Published in:
- European Heart Journal, 2024, v. 45, n. 8, p. 626, doi. 10.1093/eurheartj/ehad555
- By:
- Publication type:
- Article
Creation of next generation of diverse cardiovascular physician–scientists from developing countries: insights from Research Council of Pakistan.
- Published in:
- European Heart Journal, 2024, v. 45, n. 4, p. 243, doi. 10.1093/eurheartj/ehad493
- By:
- Publication type:
- Article
The cardiovascular effects of novel weight loss therapies.
- Published in:
- European Heart Journal, 2023, v. 44, n. 48, p. 5036, doi. 10.1093/eurheartj/ehad664
- By:
- Publication type:
- Article
Efficacy of ferric carboxymaltose in heart failure with iron deficiency: an individual patient data meta-analysis.
- Published in:
- European Heart Journal, 2023, v. 44, n. 48, p. 5077, doi. 10.1093/eurheartj/ehad586
- By:
- Publication type:
- Article
Endpoint adjudication in cardiovascular clinical trials.
- Published in:
- European Heart Journal, 2023, v. 44, n. 46, p. 4835, doi. 10.1093/eurheartj/ehad718
- By:
- Publication type:
- Article
Carat, clarity, colour, and cut: grading the DIAMOND trial.
- Published in:
- European Heart Journal, 2023, v. 44, n. 37, p. 3702, doi. 10.1093/eurheartj/ehad469
- By:
- Publication type:
- Article
2023 Focused Update of the 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: Developed by the task force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) With the special contribution of the Heart Failure Association (HFA) of the ESC
- Published in:
- European Heart Journal, 2023, v. 44, n. 37, p. 3627, doi. 10.1093/eurheartj/ehad195
- By:
- Publication type:
- Article
Leveraging electronic health records to streamline the conduct of cardiovascular clinical trials.
- Published in:
- European Heart Journal, 2023, v. 44, n. 21, p. 1890, doi. 10.1093/eurheartj/ehad171
- By:
- Publication type:
- Article
Drugs that slow the progression of diabetic kidney disease: are renoprotective effects attenuated in heart failure?
- Published in:
- European Heart Journal, 2023, v. 44, n. 17, p. 1522, doi. 10.1093/eurheartj/ehad158
- By:
- Publication type:
- Article
Improving representativeness in trials: a call to action from the Global Cardiovascular Clinical Trialists Forum.
- Published in:
- European Heart Journal, 2023, v. 44, n. 11, p. 921, doi. 10.1093/eurheartj/ehac810
- By:
- Publication type:
- Article
Empagliflozin, irrespective of blood pressure, improves outcomes in heart failure with preserved ejection fraction: the EMPEROR-Preserved trial.
- Published in:
- European Heart Journal, 2023, v. 44, n. 5, p. 396, doi. 10.1093/eurheartj/ehac693
- By:
- Publication type:
- Article
Iron deficiency and cardiovascular disease.
- Published in:
- European Heart Journal, 2023, v. 44, n. 1, p. 14, doi. 10.1093/eurheartj/ehac569
- By:
- Publication type:
- Article
Effect of empagliflozin on circulating proteomics in heart failure: mechanistic insights into the EMPEROR programme.
- Published in:
- European Heart Journal, 2022, v. 43, n. 48, p. 4991, doi. 10.1093/eurheartj/ehac495
- By:
- Publication type:
- Article
'Normal weight' is really not normal in chronic disease.
- Published in:
- 2022
- By:
- Publication type:
- Editorial
Putting the puzzle together: SGLT2 inhibitors from prevention to treatment of heart failure.
- Published in:
- European Heart Journal, 2022, v. 43, n. 41, p. 4433, doi. 10.1093/eurheartj/ehac483
- By:
- Publication type:
- Article
Patiromer for the management of hyperkalemia in heart failure with reduced ejection fraction: the DIAMOND trial.
- Published in:
- European Heart Journal, 2022, v. 43, n. 41, p. 4362, doi. 10.1093/eurheartj/ehac401
- By:
- Publication type:
- Article
Uric acid and sodium-glucose cotransporter-2 inhibition with empagliflozin in heart failure with reduced ejection fraction: the EMPEROR-reduced trial.
- Published in:
- European Heart Journal, 2022, v. 43, n. 36, p. 3435, doi. 10.1093/eurheartj/ehac320
- By:
- Publication type:
- Article
Pragmatism in clinical trials: essential, not optional.
- Published in:
- European Heart Journal, 2022, v. 43, n. 35, p. 3285, doi. 10.1093/eurheartj/ehac400
- By:
- Publication type:
- Article
Empagliflozin and serum potassium in heart failure: an analysis from EMPEROR-Pooled.
- Published in:
- European Heart Journal, 2022, v. 43, n. 31, p. 2984, doi. 10.1093/eurheartj/ehac306
- By:
- Publication type:
- Article
Non-steroidal mineralocorticoid receptor antagonists in cardiorenal disease.
- Published in:
- European Heart Journal, 2022, v. 43, n. 31, p. 2931, doi. 10.1093/eurheartj/ehac299
- By:
- Publication type:
- Article
Obesity, heart failure, and SGLT2 inhibition: DECLARE-TIMI 58 provides insights.
- Published in:
- European Heart Journal, 2022, v. 43, n. 31, p. 2968, doi. 10.1093/eurheartj/ehab709
- By:
- Publication type:
- Article
Kidney function assessment and endpoint ascertainment in clinical trials.
- Published in:
- European Heart Journal, 2022, v. 43, n. 14, p. 1379, doi. 10.1093/eurheartj/ehab832
- By:
- Publication type:
- Article
SGLT-2 Inhibitors in Heart Failure: Guide for Prescribing and Future Perspectives.
- Published in:
- Current Cardiology Reports, 2021, v. 23, n. 6, p. 1, doi. 10.1007/s11886-021-01486-3
- By:
- Publication type:
- Article
Treatment of Diabetes in Patients with Heart Failure.
- Published in:
- Current Cardiology Reports, 2018, v. 20, n. 10, p. 1, doi. 10.1007/s11886-018-1032-5
- By:
- Publication type:
- Article
Cardiac Myosin Activators in Systolic Heart Failure: More Friend than Foe?
- Published in:
- Current Cardiology Reports, 2016, v. 18, n. 10, p. 1, doi. 10.1007/s11886-016-0778-x
- By:
- Publication type:
- Article
GLP-1 Receptor Agonists and Cardiovascular Disease: What Do Clinicians Need to Know?
- Published in:
- Current Atherosclerosis Reports, 2024, v. 26, n. 8, p. 341, doi. 10.1007/s11883-024-01214-6
- By:
- Publication type:
- Article
Extended prophylaxis for venous thromboembolism after hospitalization for medical illness: A trial sequential and cumulative meta-analysis.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Validation of claims-based diagnostic and procedure codes for cardiovascular and gastrointestinal serious adverse events in a commercially-insured population.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2010, v. 19, n. 6, p. 596, doi. 10.1002/pds.1924
- By:
- Publication type:
- Article
Diagnostic and therapeutic challenges for PCPs regarding heart failure with preserved ejection fraction and obesity: results of an online internet-based survey.
- Published in:
- BMC Primary Care, 2024, v. 25, n. 1, p. 1, doi. 10.1186/s12875-024-02549-4
- By:
- Publication type:
- Article
Challenges and opportunities for increasing patient involvement in heart failure self-care programs and self-care in the post–hospital discharge period.
- Published in:
- Research Involvement & Engagement, 2023, v. 9, n. 1, p. 1, doi. 10.1186/s40900-023-00412-x
- By:
- Publication type:
- Article
Impact of empagliflozin on insulin needs in patients with heart failure and diabetes: An EMPEROR‐Pooled analysis.
- Published in:
- Diabetes, Obesity & Metabolism, 2024, v. 26, n. 7, p. 2578, doi. 10.1111/dom.15572
- By:
- Publication type:
- Article